IRIS
DI STASI, SAVINO MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 54.380
EU - Europa 5.647
AS - Asia 5.329
SA - Sud America 888
AF - Africa 79
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 14
Totale 66.354
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 54.216
SG - Singapore 2.489
IT - Italia 1.387
CN - Cina 956
UA - Ucraina 814
FR - Francia 725
BR - Brasile 703
DE - Germania 668
RU - Federazione Russa 575
HK - Hong Kong 547
IE - Irlanda 485
VN - Vietnam 427
FI - Finlandia 270
KR - Corea 228
GB - Regno Unito 222
SE - Svezia 212
JP - Giappone 150
BD - Bangladesh 145
CA - Canada 89
PL - Polonia 85
IN - India 78
ID - Indonesia 76
AR - Argentina 62
NL - Olanda 59
MX - Messico 46
CL - Cile 40
IQ - Iraq 34
ES - Italia 31
TR - Turchia 30
ZA - Sudafrica 26
EC - Ecuador 24
PK - Pakistan 23
AT - Austria 19
EG - Egitto 16
PY - Paraguay 16
VE - Venezuela 16
IL - Israele 14
MY - Malesia 14
AU - Australia 13
CO - Colombia 13
CZ - Repubblica Ceca 13
EU - Europa 13
MA - Marocco 13
DK - Danimarca 12
HU - Ungheria 12
PH - Filippine 12
AE - Emirati Arabi Uniti 11
TW - Taiwan 11
UZ - Uzbekistan 11
TH - Thailandia 10
GR - Grecia 9
KG - Kirghizistan 9
CH - Svizzera 8
IR - Iran 8
NP - Nepal 8
SA - Arabia Saudita 8
AL - Albania 6
BE - Belgio 6
DZ - Algeria 6
HN - Honduras 6
JM - Giamaica 6
PE - Perù 6
TN - Tunisia 6
KE - Kenya 5
KW - Kuwait 5
RO - Romania 5
UY - Uruguay 5
CR - Costa Rica 4
JO - Giordania 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
GE - Georgia 3
KH - Cambogia 3
LT - Lituania 3
OM - Oman 3
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
HR - Croazia 2
KZ - Kazakistan 2
LB - Libano 2
NG - Nigeria 2
NR - Nauru 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SI - Slovenia 2
SM - San Marino 2
SN - Senegal 2
A1 - Anonimo 1
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
GD - Grenada 1
GY - Guiana 1
LK - Sri Lanka 1
LV - Lettonia 1
Totale 66.342
Salva come PNG Salva come JPEG
Città #
Woodbridge 16.343
Wilmington 14.930
Houston 12.677
Singapore 1.373
Fairfield 1.221
Ashburn 812
Ann Arbor 730
Jacksonville 711
San Jose 632
Hong Kong 531
Seattle 480
Dublin 479
Chandler 463
Cambridge 399
Medford 372
Beijing 342
Santa Clara 268
Council Bluffs 247
Dearborn 239
Rome 181
Lawrence 174
New York 159
The Dalles 139
Los Angeles 135
Dallas 118
Lauterbourg 118
Helsinki 117
Moscow 113
Mülheim 113
Ho Chi Minh City 110
Buffalo 108
Tokyo 107
Hanoi 84
Milan 82
Menlo Park 76
Phoenix 68
Kraków 65
San Diego 61
São Paulo 61
Jakarta 56
Chicago 53
Dong Ket 53
University Park 50
Seongnam 41
Zhengzhou 41
London 40
Boardman 37
Nuremberg 37
Munich 32
Brooklyn 31
Falls Church 31
Frankfurt am Main 30
Columbus 29
Atlanta 28
Redondo Beach 25
Naples 24
Bologna 23
Guangzhou 23
Montreal 23
Rio de Janeiro 23
Seoul 22
Shanghai 21
Hefei 20
Toronto 20
Nanjing 19
Curitiba 18
Florence 18
Norwalk 18
Redwood City 18
San Francisco 18
Verona 18
Da Nang 17
Orem 17
Haiphong 16
Chennai 15
Temuco 15
Amsterdam 14
Kunming 14
Stockholm 14
Belo Horizonte 13
Johannesburg 13
North Bergen 13
Turin 13
Buenos Aires 12
Catania 12
Hangzhou 12
Jinan 12
Kyiv 12
Washington 12
Baghdad 11
Boston 11
Campinas 11
Denver 11
Mountain View 11
Salvador 11
Tampa 11
Warsaw 11
Wuhan 11
Brno 10
Mexico City 10
Totale 56.743
Salva come PNG Salva come JPEG
Nome #
Measurement of the thickness of the urethrovaginal space in women with or without vaginal orgasm 834
L’ecocolor Doppler nella diagnosi di prostatite granulomatosa especifica: esperienza personale. 572
New Frontiers in Intravesical Therapies and Drug Delivery 554
An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus calmette-guerin for non-muscle-invasive bladder cancer 544
Cisti intraparenchimali del didimo: aspetti ecografici. 544
Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity 536
Updates in intravesical electromotive drug administration(A (R)) of mitomycin-C for non-muscle invasive bladder cancer 530
Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens 508
La cistite emorragica da ciclofosfamide: nostra esperienza su 79 pazienti sottoposti a trapianto di midollo osseo 503
Hexaminolevulinate hydrochloride in the detection of nonmuscle invasive cancer of the bladder 503
The Nocturnal alarm as a conditioning therapy in primary nocturnal enuresis. 494
Metastasis-free survival is a strong Surrogate of overall survival in localized prostate cancer 490
Prevalence of chronic prostatitis in men with premature ejaculation. 486
A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. 485
L'Ecografia nella diagnosi dei diverticoli dell'uretra femminile. 485
Concentration-depth profiles of mitomycin-C in the human bladder wall after passive diffusion, thermochemotherapy, and electromotive drug administration. 479
Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: A pilot study 471
Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. 470
Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens 468
Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study. 467
Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. 466
Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels. 466
Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: A randomised controlled trial 463
The transcription factor FBI-1 inhibits SAM68-mediated BCL-X alternative splicing and apoptosis. 453
Pelvic floor muscle behavior during Valsalva leak point pressure measurement in males and females affected by stress urinary incontinence. 452
La cistite emorragica da ciclofosfamide: nostra esperienza su 79 pazienti sottoposti a trapianto di midollo osseo. 452
Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients. 452
Intermittent catheterization with a prelubricated catheter in spinal cord injured patients: A prospective randomized crossover study 451
Retropubic, laparoscopic, and robot-assisted radical prostatectomy: surgical, oncological, and functional outcomes: a systematic review. 451
Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study. 450
Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease 448
Electromotive delivery of mitomycin C into human bladder wall 448
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non–muscle-invasive bladder cancer 446
Cavernous hemangioma of the renal hilum presenting as an avascularized solid mass 441
The efficacy and safety of duloxetine in a multidrug regimen for chronic prostatitis/chronic pelvic pain syndrome. 441
Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial. 441
Lower urinary tract dysfunction and disability status in patients with multiple sclerosis 440
Alfa-2a-interferon in neoadjuvant and adjuvant therapy of superficial ladder cancer: preliminary results. 440
Tissue pharmacokinetics of mitomycin-c in the human bladder wall after passive diffusion, thermo-chemotherapy and electromotive drug administration. 440
Ontogenetic profile and thyroid hormone regulation of type-1 and type-8 glucose transporters in rat Sertoli cells. 439
Electromotive administration of oxybutynin into the human bladder wall. 438
Intravesical adjuvant electromotive drug administration (EMDA®) of mitomycin-C in patients with intermediate-risk non-muscle invasive bladder cancer: A randomized controlled trial 436
Electromotive versus passive diffusion of mitomycin C into human bladder wall: concentration-depth profiles studies 432
Diuretic ultrasound. A non-invasive technique for the assessment of upper tract obstruction. 431
La terapia intralesionale dei tumori superficiali a cellule transizionali della vescica con interferone alfa ricombinante 430
Electromotive delivery of mitomycin C into human bladder wall 429
Successful management of retroperitoneal malignant fibrous histiocytoma involving both kidneys 428
Quality of life after radical prostatectomy or external beam radiotherapy for localized prostate cancer: a controlled prospective study. 427
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin 426
Platelet-derived growth factor regulation of type-5 phosphodiesterase in human and rat penile smooth muscle cells. 423
Clean intermittent catheterization and prevention of renal disease in spinal cord injury patients 421
Single preoperative intravesical instillation of electromotive mitomycin-c for primary non-muscle invasive bladder cancer: a prospective randomized trial. 421
Single immediate preoperative intravesical instillation of electromotive mitomycin-C for low risk superficial bladder cancer: A prospective randomized study. 420
Intralesional alpha interferon therapy in papillary superficial transitional cell carcinoma of the bladder. A pilot study. 419
Adjuvant alpha-interferon in renal cell carcinoma at high risk of relapse. A multicentre pilot study. 419
Intravesical electro-osmotic administration of mitomycin C 419
A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease 416
Extraction and determination of oxybutynin in human bladder samples by reversed-phase high-performance liquid chromatography. 416
Intravesical electromotive drug administration. 416
Urodynamic assessment of bladder and urethral sphincter function before radical prostatectomy and during long-term follow-up. 415
The human bladder urothelium: new concepts and future perspectives. 415
Gender identity rather than sexual orientation impacts on facial preferences. 414
The bladder urothelium: passive permeabilità and intravesical drug passive diffusion. 413
Diverticoli uretrali ed ascessi parauretrali nella donna: nostra esperienza. 412
Successful management of retroperitoneal malignant fibrous histiocytoma involving both kidneys. 408
Intravesical sequential BCG and electromotive mitomycin versus BCG alone in high risk non-muscle invasive bladder cancer 408
Intravesical sequential BCG and electromotive mitomycin versus BCG alone for stage pT1 urothelial bladder cancer 408
Celecoxib for the prevention of nonmuscle invasive bladder cancer: Results from a matched control study 408
Intravesical electromotive administration of oxybutynin: from laboratoty to clinica field. 406
Intralesional alpha interferon therapy in papillary superficial transitional cell carcinoma of the bladder. A pilot study 404
Tumori vescicali intradiverticolari. Diagnosi preoperatoria. 404
Prognostic Factors And Risk Groups In T1g3 Patients Initially Treated With Bcg: Results Of A Multicenter Retrospective Series In 2530 Patients 404
BCG nel carcinoma vescicale 403
Autonomic dysreflexia during urodynamics 402
Our experience with Epirubicin in the treatmnet of superficial bladder tumors after conservative therapy. 402
Lower urinary tract dysfunction and disability status in patients with multiple sclerosis 401
Intravesical electromotive drug administration of mitomycin-C for non-muscle invasive bladder cancer 400
Contemporary management of non-muscle invasive bladder cancer at italian referral centres adopting eau guidelines 400
Percutaneous sequential bacillus Calmette-Guérin and mitomycin C for panurothelial carcinomatosis. 399
Valsalva leak point pressure 399
Intravesical sequential bacillus Calmette-Guérin and electromotive mitomycin versus bacillus Calmette-Guérin alone for stage pt1 urothelial bladder cancer 398
Malattia di La Peyronie. 395
Color Doppler echography in the diagnosis of nonspecific granulomatous prostatis: personal experience. 392
Clean intermittent catheterization and prevention of renal disease in spinal cord injury patients. 392
Transdermal electromotive administration of verapamil and dexametasone for Peyronie’s disease 391
Diuretic ultrasound. A non-invasive technique for the assessment of upper tract obstruction 390
Percutaneous sequential bacillus Calmette-Guèrin and mitomycin C for panurothelial carcinomatosis 390
Cavernous hemangioma of the renal hilum presenting as an avascularized solid mass. 390
Defibrotide versus eparina calcica nella profilassi della trombosi venosa profonda in chirurgia urologica: studio randomizzato. 387
Percutaneous sequential bacillus Calmette-Guèrin and mitomycin C for panurothelial carcinomatosis. 385
Extracorporeal piezoelectric lithotripsy: experience in 930 patients. 383
Intravesical therapy with mitomycin through electromotive drug administration. 383
Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial 381
Single preoperative intravesical instillation of electromotive anitomycin-C for primary non-muscle-invasive bladder cancer: A prospective randonsied trial 381
Il drenaggio percutaneo ecoguidato transperineale delle raccolte pelviche 380
Intravesical Sequential BCG and Elecromotive Mitomycin-C versus BCG Alone for Stage pT1 Urothelial Bladder Cancer. 379
Long-term followup analysis of a randomized prospective study comparing intravesical electromotive mitomycin-C, passive diffusion mitomycin-C and bacillus Calmette-Guerin in patients with carcinoma in situ of the bladder. 379
Intravesical oxybutynin: mode of action assessed by passive diffusion and electromotive administration with pharmacokinetics of oxybutynin and N-desethyl oxybutynin. 378
Il ruolo dell'ecografia nello studio delle neoplasie della via escretrice superiore 377
Cavernous hemangioma of the renal hilum presenting as an avascularized solid mass 375
Totale 43.701
Salva come PNG Salva come JPEG
Categoria #
all - tutte 137.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.546
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.634 50 247 86 120 62 91 86 76 93 122 78 523
2022/20231.715 211 104 47 155 123 426 172 96 113 40 175 53
2023/2024782 70 41 83 47 51 93 90 46 43 45 22 151
2024/20254.080 163 993 454 191 80 346 207 132 258 313 506 437
2025/20266.471 503 261 837 404 535 311 844 675 709 735 384 273
2026/20275 5 0 0 0 0 0 0 0 0 0 0 0
Totale 66.730